Merck KGaA, Darmstadt, Germany Announces Update on the INTR@PID Clinical Program Including Lung 037 StudyPRNewsWire • 01/20/21
Merck Just Sold Its Equity Stake In Moderna — But Is Merck Stock A Buy?Investors Business Daily • 01/20/21
U.S. FDA Accepts for Priority Review the Biologics License Application for V114, Merck's Investigational 15-valent Pneumococcal Conjugate Vaccine, for Use in Adults 18 Years of Age and OlderBusiness Wire • 01/12/21
Merck & Co., Inc. (MRK) CEO Ken Frazier Presents at 39th Annual JPMorgan Healthcare Conference (Transcript)Seeking Alpha • 01/12/21
Merck to Hold Fourth-Quarter and Full-Year 2020 Sales and Earnings Conference Call on February 4Business Wire • 01/08/21
The Dogs of the Dow Didn't Hunt in 2020, and 2021 Isn't Looking Much BetterThe Motley Fool • 01/07/21